전자 약국 시장 기회, 성장 촉진요인, 업계 동향 분석 및 예측(2026-2035년)

The Global E-Pharmacy Market was valued at USD 107.4 billion in 2025 and is estimated to grow at a CAGR of 12.8% to reach USD 357.2 billion by 2035.

The market is experiencing significant expansion as consumers increasingly prefer convenient, accessible, and digitally connected healthcare services. Higher internet penetration, widespread smartphone usage, and the growing adoption of digital healthcare platforms are making it easier for consumers to purchase prescription and over-the-counter (OTC) medications online. Demand is particularly strong among individuals requiring recurring prescription refills and long-term medication management. Continuous improvements in digital infrastructure are further supporting market development by enabling secure online transactions, streamlined prescription processing, and efficient home delivery services. E-pharmacy platforms are transforming the healthcare purchasing experience by providing greater accessibility, enhanced privacy, and improved convenience while minimizing the need for visits to traditional pharmacies. Growing consumer confidence in digital healthcare services, combined with continuous technological advancements and expanding online healthcare ecosystems, is expected to create substantial long-term opportunities for the e-pharmacy market while encouraging broader adoption of digital pharmaceutical services across global healthcare systems.

The e-pharmacy market continues to benefit from the rapid expansion of digital healthcare infrastructure, which is improving accessibility to medicines and healthcare products through online platforms. These platforms enable consumers to purchase prescription medications, OTC products, and various healthcare essentials through digital channels while offering convenient doorstep delivery and remote ordering capabilities. The competitive landscape remains highly dynamic as companies continue to strengthen their market position through ongoing platform enhancements, geographic expansion, advanced digital technologies, investments in data analytics, and continuous improvements in customer experience. These initiatives are helping providers deliver more efficient, secure, and user-friendly healthcare purchasing solutions while expanding their customer base across diverse markets.

The OTC segment accounted for 36.3% share in 2025, making it the leading category. Segment growth is supported by increasing consumer preference for self-care, convenient access to non-prescription medications, and rising awareness of preventive healthcare. Consumers increasingly purchase OTC medicines and wellness products online because they offer fast, convenient access without requiring a prescription. Growing demand for vitamins, dietary supplements, immunity-support products, personal care items, and other wellness solutions is further accelerating market expansion.

Based on operating model, the inventory segment held 48.7% share in 2025 and is projected to reach USD 167.1 billion during 2026-2035. The inventory-based model maintains its leadership by offering stronger control over product authenticity, inventory management, quality assurance, and faster order fulfillment. These capabilities are particularly valuable within the pharmaceutical industry, where product quality, regulatory compliance, and supply chain reliability are essential. Direct inventory management also enables companies to improve pricing strategies, optimize distribution efficiency, strengthen quality control, and enhance customer confidence, contributing to sustained demand for this operating model.

U.S. e-Pharmacy Market was valued at USD 38.2 billion in 2025, supported by the widespread adoption of digital healthcare technologies and a highly developed healthcare ecosystem. Increasing utilization of electronic prescriptions, telehealth services, electronic health records, and automated prescription refill systems continues to support market expansion. Strong coordination among healthcare providers, insurers, and pharmacy platforms has created a highly integrated medication management framework, enabling efficient prescription fulfillment and improving the overall customer experience across the United States.

Key companies operating in the global e-pharmacy market include Amazon Pharmacy, CVS Health, Walgreens Boots Alliance, JD Health, Alibaba Health, Optum Rx (UnitedHealth Group), Express Scripts Holdings (Cigna), Walmart, Capsule, Alto Pharmacy, Ping An Good Doctor, Rite Aid, The Kroger Co., Giant Eagle, and MedsEngage. Leading companies in the e-pharmacy market are strengthening their market position by investing in advanced digital technologies, expanding product portfolios, and improving platform functionality to deliver seamless customer experiences. Businesses are enhancing mobile applications, integrating artificial intelligence for personalized healthcare services, and utilizing data analytics to optimize inventory management and customer engagement. Strategic partnerships, acquisitions, and geographic expansion remain key approaches for increasing market reach and strengthening competitive positioning. Companies are also investing in faster delivery networks, secure digital prescription processing, automated fulfillment systems, and robust supply chain capabilities to improve operational efficiency.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope and definition
• 1.2 Research approach
• 1.3 Quality commitments
  • 1.3.1 GMI AI policy & data integrity commitment
    • 1.3.1.1 Source consistency protocol
• 1.4 Research trail & confidence scoring
  • 1.4.1 Research trail components
  • 1.4.2 Scoring components
• 1.5 Data collection
  • 1.5.1 Partial list of primary sources
• 1.6 Data mining sources
  • 1.6.1 Paid sources
    • 1.6.1.1 Sources, by region
• 1.7 Base estimates and calculations
  • 1.7.1 Base year calculation for any one approach
• 1.8 Forecast model
  • 1.8.1 Quantified market impact analysis
    • 1.8.1.1 Mathematical impact of growth parameters on forecast
• 1.9 Research transparency addendum
  • 1.9.1 Source attribution framework
  • 1.9.2 Quality assurance metrics
  • 1.9.3 Our commitment to trust

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Product trends
  • 2.2.3 Therapeutic area trends
  • 2.2.4 Platform trends
  • 2.2.5 Business model trends
• 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rise in the number of internet users worldwide
    • 3.2.1.2 Increasing access to web-based and online services
    • 3.2.1.3 Lucrative offers and discounts along with easy availability of online prescription drugs
    • 3.2.1.4 Expanding geriatric population base coupled with growing prevalence of chronic disorders
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Increasing number of illegal online pharmacies
    • 3.2.2.2 Risk of counterfeit drugs
  • 3.2.3 Market opportunities
    • 3.2.3.1 Integration of AI-powered telepharmacy
    • 3.2.3.2 Personalized wellness and preventive care products
• 3.3 Growth potential analysis
• 3.4 Technology landscape
  • 3.4.1 Current technology
  • 3.4.2 Emerging technologies
• 3.5 Pricing analysis (Driven by Primary Research)
• 3.6 Regulatory landscape (Driven by primary research)
  • 3.6.1 North America
  • 3.6.2 Europe
  • 3.6.3 Asia Pacific
  • 3.6.4 Latin America
  • 3.6.5 Middle East and Africa
• 3.7 Porter's analysis
• 3.8 PESTEL analysis
• 3.9 Impact of AI and generative AI on the market
• 3.10 Future market trends (Driven by primary research)
• 3.11 Current and future scenario of online pharmacies
• 3.12 E-pharmacy market script volume, by payer mix
• 3.13 E-pharmacy business models
• 3.14 Bifurcation between OTC and Rx

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Key developments
  • 4.5.1 Merger and acquisition
  • 4.5.2 Partnership and collaboration
  • 4.5.3 New product launches
  • 4.5.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Rx medicines
• 5.3 OTC
• 5.4 Other products

Chapter 6 Market Estimates and Forecast, By Therapeutic Area, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Pain Management
• 6.3 Cardiovascular Diseases
• 6.4 Diabetes & Metabolic Disorders
• 6.5 Respiratory Disorders
• 6.6 Gastrointestinal (Digestive Health)
• 6.7 Dermatology / Skin Care
• 6.8 Women's Health
• 6.9 Mental health
• 6.10 Other therapeutic areas

Chapter 7 Market Estimates and Forecast, By Platform, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 Web based
• 7.3 App based

Chapter 8 Market Estimates and Forecast, By Business Model, 2022 - 2035 ($ Mn)

• 8.1 Key trends
• 8.2 Inventory
• 8.3 Marketplace
• 8.4 Hybrid

Chapter 9 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Alibaba Health
• 10.2 Alto Pharmacy
• 10.3 Amazon Pharmacy
• 10.4 Capsule
• 10.5 CVS Health
• 10.6 Express Scripts Holdings (Cigna)
• 10.7 Giant Eagle
• 10.8 JD Health
• 10.9 MedsEngage
• 10.10 Optum Rx (UnitedHealth Group)
• 10.11 Ping An Good Doctor
• 10.12 Rite Aid
• 10.13 The Kroger Co.
• 10.14 Walgreens Boots Alliance
• 10.15 Walmart